ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
SD
Santiago de Compostela University Clinical Hospital at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Santiago de Compostela University Clinical Hospital takes part in 5 sessions at ESMO 2026 in Madrid. Its work covers colorectal, breast and kidney cancers, including treatment outcomes and molecular testing. It examines real-world outcomes with trifluridine and tipiracil plus bevacizumab in metastatic colorectal cancer.
| Organization | ESMO 2026 Attendance |
|---|---|
SD Santiago de Compostela University Clinical Hospital Santiago de Compostela, Spain | |
University clinical hospital providing healthcare in Santiago de Compostela, Spain. | Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Molecular characterization of breast cancer metastatic recurrence through circulating tumor cell gene expression analysis Breast cancerBiomarkers & precision oncology Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Prevalence of PI3K alterations and incidental molecular findings by NGS in an adjuvant colorectal cancer registry Gastrointestinal cancersBiomarkers & precision oncology Poster Sun Oct 25 12:00–12:45 |
Find decision makers at Santiago de Compostela University Clinical Hospital
Tell us what you sell and we’ll find the people at Santiago de Compostela University Clinical Hospital most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction